XML 36 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2019
Sep. 29, 2018
Sep. 28, 2019
Sep. 29, 2018
Operating activities        
Net earnings (loss) $ (11,779) $ (4,536) $ 4,904 $ (12,124)
Items not affecting cash:        
Depreciation and amortization 8,517 8,171 25,005 24,501
Amortization of debt issuance costs 683 598 2,022 1,806
Deferred income taxes (2,732) (1,706) 2,239 (3,857)
Stock-based compensation 2,558 2,120 5,393 6,395
Unrealized loss on derivative contracts 865 2,110 577 867
Loss (gain) on sale of business 1,109 0 (44,269) 0
Fair value of contingent consideration   25   (2,348)
Impairment of long-lived assets       409
Other 26 36 (108) (111)
Changes in non-cash working capital, net of businesses acquired or sold 5,042 3,664 (22,146) (31,771)
Net cash flows from operations 4,289 10,482 (26,383) (16,233)
Investing activities        
Net proceeds from sale of business (3) 1,006 64,672 1,236
Purchases of property, plant and equipment (7,592) (7,758) (24,907) (24,921)
Acquisition of business, net of cash acquired     (3,341)  
Proceeds from sale of assets   707   1,437
Other       159
Net cash flows from investing activities (7,595) (6,045) 36,424 (22,089)
Financing activities        
Increase (decrease) under line of credit facilities 4,603 (2,716) (6,691) 47,478
Borrowings under long-term debt 565   2,441  
Repayment of long-term debt (556) (557) (1,913) (1,494)
Payment of cash dividends on Series A Preferred Stock (1,700) (1,700) (5,100) (5,100)
Proceeds from the exercise of stock options and employee share purchases 164 359 429 599
Payment of debt issuance costs     (395)  
Dividend paid by subsidiary to non-controlling interest (31)   (31)  
Payment of contingent consideration       (4,399)
Other (5) (44) 211 (89)
Net cash flows from financing activities 3,040 (4,658) (11,049) 36,995
Foreign exchange loss on cash held in a foreign currency (55) (9) (63) (44)
Decrease in cash and cash equivalents in the period (321) (230) (1,071) (1,371)
Cash and cash equivalents - beginning of the period 2,530 2,087 3,280 3,228
Cash and cash equivalents - end of the period $ 2,209 $ 1,857 $ 2,209 $ 1,857